Muscle excitability may be either pathologically enhanced or reduced as a consequence of Nav1.4 gain-of-function mutations leading to non-dystrophic myotonias (NDMs) or periodic paralysis, respectively. This evidence concerns the gene SCN4A and periodic paralysis.